**Education and Professional Experience:** **Education:** 1979-09 ~ 1984-06 Sun Yat-sen University of Medical Sciences Bachelor's Degree 1990-09 ~ 1993-06 Sun Yat-sen University of Medical Sciences Master's Degree 1999-09 ~ 2002-06 Sun Yat-sen University Doctoral Degree **Professional Experience:** 1984-07 ~ 1994-11 Resident Physician, The First Affiliated Hospital of Sun Yat-sen University of Medical Sciences 1994-12 ~ 1998-11 Attending Physician/Lecturer, The First Affiliated Hospital of Sun Yat-sen University of Medical Sciences 1998-12 ~ 2004-11 Associate Professor/Associate Chief Physician, The First Affiliated Hospital of Sun Yat-sen University 2004-12 ~ Present Professor/Chief Physician, The First Affiliated Hospital of Sun Yat-sen University **Professional Affiliations:** Currently serves as Immediate Past Chair of the Hematology Branch of Guangdong Medical Association, Chair of the Hematology Physician Branch of Guangdong Medical Doctor Association, Chair of the Hematology Professional Committee of Guangdong Health Management Association, Standing Committee Member of the Chinese Society of Hematology, Chinese Medical Association, Standing Committee Member of the Hematology Physician Branch of Chinese Medical Doctor Association, Vice Chair of the Multiple Myeloma Professional Committee of Chinese Medical Doctor Association, Chair of the Plasma Cell Disease Group of the Chinese Society of Hematology, Chinese Medical Association, Chair-elect of the Hematology Professional Committee of Chinese Women Medical Doctors Association, Member of the International Myeloma Society, Member of the Asian Myeloma Network, among other positions. **Publications:** Published over 190 papers as first author or corresponding author, including over 60 indexed in SCI. 1. Xu XX; Zhang C; Trotter T; Gowda P; Lu Y; Selvarangan Ponnazhagan; Javed A; Li J*; Yang Y*; Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites, Cancer Res, 2020, 80(5): 1036-1048. (IF 8.87) 2. Li XZ#; Chen WM#; Li JY; Chen LJ; Fang BJ; Feng Y; Liu JR; Chen ML; Gu JL; Huang BH; Li J*; 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China, Oncologist, 24(11): E1132-E1140. (IF 5.306) 3. Gu JL; Liu JR; Chen ML; Huang BH; Li J*; Longitudinal Flow Cytometry Identified "Minimal Residual Disease" (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma, Biol Blood Marrow Transplant, 2018, 24(12): 2568-2574. (IF 4.484) 4. Xu LM; Liu JR; Chen ML; Kuang LF; Huang BH; Gu JL; Li J*; Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma, Ann Hematol, 2020, 99(3): 581-589. (IF 2.85) 5. Sun T; Wang S; Sun H; Wen J; An G; Li J*; Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades, Leuk Lymphoma, 2018,59(1):49-58. (IF 2.674) 6. He GL; Xu DR; Zou WY; He SZ; Li J*; The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis, Biomed Res Int, 2018, 2018:3936706. (IF 2.583) 7. Huang B#; Lu J#; Wang X; Xiao Y; Zhao Y; Huang H; Liu J; Chen M; Gu J; Yuan S; Zheng D; Li Y; Huang X*;Li J*; Prognostic value of lactate dehydrogenase in Chinese patients with newly diagnosed transplant eligible multiple myeloma, Leuk Lymphoma, 2017,58(7):1740-1742. (IF 2.644) 8. Zheng D#; Chen Z#; Chen J; Zhuang X; Feng J; Li J*; Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, migration effects and accelerates cell cycle progression in multiple myeloma cells via activating the Akt pathway, Oncol Rep, 2016,36(4):1909-1916. (IF 2.486) 9. Huang B#; Li J#*; Liu J; Gu J; CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients? Leuk Lymphoma, 2016,57(2):335-340. (IF 2.755) 10. Li J#; Pan Q#; Rowan PD#; Trotter TN; Peker D; Regal K M; Javed A; Suva L J; Yang Y*; Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells, Oncotarget, 2016,7(10):11299-11309. (IF 5.008) 11. Li J#*; Huang B#; Li Y; Zheng D; Zhou Z; Liu J; Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant, Leuk Lymphoma, 2015,56(6):1710-1717. (IF 3.093) 12. Li J#*; Ouyang Y#; Zhang X; Zhou W; Wang F; Huang Z; Wang X; Chen Y; Zhang H; Fu L*; Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo, Am J Cancer Res, 2015,5(3):1000-1016. (IF 4.165) **Books:** 1. *Concise Differential Diagnosis of Hematologic Diseases* 2016-01 People's Medical Publishing House Editor-in-Chief 2. *Questions and Answers on Multiple Myeloma* 2015-02 People's Medical Publishing House Editor-in-Chief 3. *Analysis of Challenging Hematology Cases and Diagnostic Approaches* 2014-03 Guangdong Science and Technology Press Editor-in-Chief 4. *Clinical Diagnosis and Treatment Protocols for Hematologic Diseases* 2010-06 Scientific and Technical Documentation Press Editor-in-Chief 5. *Multiple Myeloma - Current Status and Advances* 2010-05 People's Military Medical Press Editor-in-Chief 6. *Clinical Hematology* 2003-01 Science Press Editor-in-Chief 7. *Differential Diagnosis of Internal Medicine Diseases* 2014-08 People's Medical Publishing House Associate Editor-in-Chief **Other Major Achievements:** 1. "Investigation of New Treatment Methods and Their Mechanisms for Refractory/Relapsed Multiple Myeloma" - Awarded First Prize of Guangdong Provincial Science and Technology Progress Award (2006), First Completer 2. "Achieving the Goal of Transforming Multiple Myeloma into a Chronic Disease through Integrated Treatment" - Awarded Third Prize of Guangdong Provincial Science and Technology Progress Award (2016), First Completer 3. "Optimizing and Comprehensively Improving the Overall Treatment and Outcomes for Young Patients with Multiple Myeloma" - Awarded Second Prize of Huaxia Medical Science and Technology Award (2019), First Completer 4. Sixth China Women Medical Doctors Association Wuzhou Women's Science and Technology Award - Clinical Medical Research Innovation Award (2019) Guangdong Province March 8th Red-Banner Holder (2018)